This inventor holds 1 USPTO granted patent. Top assignee: The United States of America as Represented by the Department of Health. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: M K Bhan: Innovator in Rotavirus Research
Introduction
M K Bhan is a prominent inventor based in New Delhi, India. He has made significant contributions to the field of virology, particularly in the study of rotaviruses. His work has implications for public health, especially in the context of immunization protocols.
Latest Patents
M K Bhan holds a patent for the isolated rotavirus strain G9P11. This patent includes an isolated nucleic acid encoding the rotavirus of strain G9P11 and a purified antigen specific for the rotavirus. Additionally, it provides an isolated nucleic acid that selectively hybridizes under high stringency conditions with the nucleic acid encoding the virus. The patent also describes a purified antibody that selectively binds the virus of strain G9P11. Furthermore, the G9P11 rotavirus is presented in a pharmaceutically acceptable carrier for administration in an immunization protocol. The patent details variations of the G9P11 strain, including substitutions in the G9 and P11 genes.
Career Highlights
M K Bhan has had a distinguished career, working with the United States of America as represented by the Department of Health. His research has been pivotal in advancing our understanding of rotavirus and its implications for vaccine development.
Collaborations
Throughout his career, M K Bhan has collaborated with notable colleagues, including John R Gentsch and Bimal K Das. These collaborations have further enriched his research and contributed to the scientific community's knowledge of rotaviruses.
Conclusion
M K Bhan's innovative work in rotavirus research has led to significant advancements in the field. His patent for the G9P11 strain exemplifies his commitment to improving public health through scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
